| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74b7b50944d8e1960440fb1f5440b7fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-569 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-46 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2018-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa75c4e7e9faba90b0300e407aa0955b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feb78fa4f5aeaf9982166a23718177cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d11382597d80c90bad4dd3cfd5d2223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f30b87a151fce50bacf90f65139c56e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_defa53e47f329a340dc8b9d8bcac268f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac67035db7f401f9b577c9fb77310b17 |
| publicationDate |
2020-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112019028269-A2 |
| titleOfInvention |
polypeptides that bind to complement c5 component or serum albumin and its fusion proteins |
| abstract |
the present invention relates to engineered polypeptides that specifically bind to the human complement and / or serum albumin c5 component. the present invention also relates to fusion proteins that comprise such engineered polypeptides, wherein such fusion proteins can be multivalent and very specific proteins. the present invention further relates to nucleic acid molecules that encode such engineered polypeptides or fusion proteins. the description further provides pharmaceutical compositions comprising such engineered polypeptides or fusion proteins and methods of treatment using such engineered polypeptides or fusion proteins. |
| priorityDate |
2017-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |